| A blood RNA signature for tuberculosis disease risk: a prospective cohort study DE Zak, A Penn-Nicholson, TJ Scriba, E Thompson, S Suliman, LM Amon, ... The Lancet 387 (10035), 2312-2322, 2016 | 824 | 2016 |
| Four-gene pan-African blood signature predicts progression to tuberculosis S Suliman, EG Thompson, J Sutherland, J Weiner 3rd, MOC Ota, ... American journal of respiratory and critical care medicine 197 (9), 1198-1208, 2018 | 284 | 2018 |
| Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease TJ Scriba, A Penn-Nicholson, S Shankar, T Hraha, EG Thompson, ... PLoS pathogens 13 (11), e1006687, 2017 | 235 | 2017 |
| Functions of notch signaling in the immune system: consensus and controversies JS Yuan, PC Kousis, S Suliman, I Visan, CJ Guidos Annual review of immunology 28 (1), 343-365, 2009 | 232 | 2009 |
| First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults AKK Luabeya, BMN Kagina, MD Tameris, H Geldenhuys, ST Hoff, Z Shi, ... Vaccine 33 (33), 4130-4140, 2015 | 223 | 2015 |
| Bacillus Calmette–Guérin (BCG) revaccination of adults with latent Mycobacterium tuberculosis infection induces long-lived BCG-reactive NK cell responses S Suliman, H Geldenhuys, JL Johnson, JE Hughes, E Smit, M Murphy, ... The Journal of Immunology 197 (4), 1100-1110, 2016 | 162 | 2016 |
| Metabolite changes in blood predict the onset of tuberculosis J Weiner 3rd, J Maertzdorf, JS Sutherland, FJ Duffy, E Thompson, ... Nature communications 9 (1), 5208, 2018 | 149 | 2018 |
| RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response A Penn-Nicholson, SK Mbandi, E Thompson, SC Mendelsohn, S Suliman, ... Scientific reports 10 (1), 8629, 2020 | 132 | 2020 |
| Single-cell eQTL models reveal dynamic T cell state dependence of disease loci A Nathan, S Asgari, K Ishigaki, C Valencia, T Amariuta, Y Luo, JI Beynor, ... Nature 606 (7912), 120-128, 2022 | 129 | 2022 |
| Dose optimization of H56: IC31 vaccine for tuberculosis-endemic populations. A double-blind, placebo-controlled, dose-selection trial S Suliman, AKK Luabeya, H Geldenhuys, M Tameris, ST Hoff, Z Shi, ... American journal of respiratory and critical care medicine 199 (2), 220-231, 2019 | 102 | 2019 |
| Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study A Penn-Nicholson, T Hraha, EG Thompson, D Sterling, SK Mbandi, ... PLoS medicine 16 (4), e1002781, 2019 | 98 | 2019 |
| Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment and disease A Nathan, JI Beynor, Y Baglaenko, S Suliman, K Ishigaki, S Asgari, ... Nature immunology 22 (6), 781-793, 2021 | 76 | 2021 |
| Early progression to active tuberculosis is a highly heritable trait driven by 3q23 in Peruvians Y Luo, S Suliman, S Asgari, T Amariuta, Y Baglaenko, M Martínez-Bonet, ... Nature communications 10 (1), 3765, 2019 | 68 | 2019 |
| MR1-independent activation of human mucosal-associated invariant T cells by mycobacteria S Suliman, M Murphy, M Musvosvi, A Gela, EW Meermeier, H Geldenhuys, ... The Journal of Immunology 203 (11), 2917-2927, 2019 | 67 | 2019 |
| T cell autoreactivity directed toward CD1c itself rather than toward carried self lipids KS Wun, JF Reijneveld, TY Cheng, K Ladell, AP Uldrich, J Le Nours, ... Nature immunology 19 (4), 397-406, 2018 | 65 | 2018 |
| T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection M Musvosvi, H Huang, C Wang, Q Xia, V Rozot, A Krishnan, P Acs, ... Nature Medicine 29 (1), 258-269, 2023 | 57 | 2023 |
| Immunometabolic signatures predict risk of progression to active tuberculosis and disease outcome FJ Duffy, J Weiner III, S Hansen, DL Tabb, S Suliman, E Thompson, ... Frontiers in immunology 10, 527, 2019 | 51 | 2019 |
| Effect of isoniazid therapy for latent tb infection on quantiferon-Tb gold in-Tube responses in adults with positive tuberculin skin test results in a high tb incidence area JL Johnson, H Geldenhuys, BA Thiel, A Toefy, S Suliman, B Pienaar, ... Chest 145 (3), 612-617, 2014 | 48 | 2014 |
| A serum circulating miRNA signature for short-term risk of progression to active tuberculosis among household contacts FJ Duffy, E Thompson, K Downing, S Suliman, H Mayanja-Kizza, ... Frontiers in immunology 9, 661, 2018 | 46 | 2018 |
| Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults M Hatherill, H Geldenhuys, B Pienaar, S Suliman, P Chheng, ... Vaccine 32 (31), 3982-3988, 2014 | 46 | 2014 |